Pfizer predicts a $15 billion profit in 2021 from Covid-19 vaccine

One of the worlds leading pharmaceutical giants Pfizer on Tuesday said that it is expecting around $15 million profit from Covid-19 vaccines in 2021 from all around the world. The company operates with a partnership deal with German pharmaceutical BioNtech.

The company expects a sale in the range of 59 billion to 61 billion for this year alone.

Pfizer is among the frontrunners to get authorization to be administered in countries like the US and likewise countries.